| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $15.6M | — |
| R&D Expense | $9.0M | -4.4% |
| SG&A Expense | $7.8M | -8.3% |
| Operating Income | -$1.1M | +93.7% |
| Pre-tax Income | -$838K | +94.6% |
| Income Tax | -$468K | -436.4% |
| Net Income | -$370K | +97.6% |
| EPS (Basic) | -$0.23 | -2200.0% |
| EPS (Diluted) | -$0.23 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.2M | +12.7% |
| Accounts Receivable | $12K | -90.6% |
| Current Assets | $15.0M | +14.0% |
| Total Assets | $28.6M | +3.4% |
| Current Liabilities | $4.2M | +10.2% |
| Total Liabilities | $9.6M | -5.6% |
| Stockholders' Equity | $19.0M | +8.6% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $77K | +100.5% |
| Financing Cash Flow | $1.5M | -89.9% |
| -2200.0% |